Medidata Solutions Inc (MDSO) CFO Rouven Bergmann Sells 2,000 Shares

Medidata Solutions Inc (NASDAQ:MDSO) CFO Rouven Bergmann sold 2,000 shares of the firm’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $66.46, for a total value of $132,920.00. Following the completion of the sale, the chief financial officer now directly owns 87,775 shares in the company, valued at $5,833,526.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Rouven Bergmann also recently made the following trade(s):

  • On Tuesday, December 19th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The stock was sold at an average price of $65.95, for a total value of $131,900.00.
  • On Thursday, November 30th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The stock was sold at an average price of $65.40, for a total value of $130,800.00.

Medidata Solutions Inc (MDSO) traded up $0.16 during mid-day trading on Monday, hitting $67.02. 797,637 shares of the stock traded hands, compared to its average volume of 473,821. Medidata Solutions Inc has a 1 year low of $47.77 and a 1 year high of $85.92. The stock has a market capitalization of $3,908.70, a price-to-earnings ratio of 95.74, a price-to-earnings-growth ratio of 3.46 and a beta of 1.69. The company has a quick ratio of 3.37, a current ratio of 1.29 and a debt-to-equity ratio of 0.61.

Medidata Solutions (NASDAQ:MDSO) last released its earnings results on Thursday, October 26th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.02. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. The firm had revenue of $140.08 million during the quarter, compared to analyst estimates of $141.27 million. During the same period last year, the business earned $0.28 earnings per share. The business’s revenue was up 16.7% on a year-over-year basis. analysts forecast that Medidata Solutions Inc will post 0.78 earnings per share for the current year.

Hedge funds have recently added to or reduced their stakes in the company. Fortaleza Asset Management Inc. purchased a new position in shares of Medidata Solutions during the third quarter valued at approximately $155,000. Polen Capital Management LLC purchased a new position in shares of Medidata Solutions during the third quarter valued at approximately $205,000. Cubist Systematic Strategies LLC purchased a new position in shares of Medidata Solutions during the second quarter valued at approximately $227,000. ETF Managers Group LLC purchased a new position in shares of Medidata Solutions during the second quarter valued at approximately $233,000. Finally, Hanseatic Management Services Inc. lifted its holdings in shares of Medidata Solutions by 14,915.0% during the third quarter. Hanseatic Management Services Inc. now owns 3,003 shares of the company’s stock valued at $234,000 after purchasing an additional 2,983 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Several analysts have commented on MDSO shares. Deutsche Bank started coverage on shares of Medidata Solutions in a report on Friday, December 8th. They issued a “buy” rating and a $78.00 price objective for the company. SunTrust Banks restated a “buy” rating and issued a $92.00 price objective on shares of Medidata Solutions in a report on Friday, October 27th. Dougherty & Co upgraded shares of Medidata Solutions from a “neutral” rating to a “buy” rating and set a $75.00 price objective for the company in a report on Monday, November 13th. TheStreet lowered shares of Medidata Solutions from a “b” rating to a “c+” rating in a report on Thursday, December 14th. Finally, Royal Bank of Canada restated a “hold” rating and issued a $80.00 price objective on shares of Medidata Solutions in a report on Friday, October 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $84.54.

ILLEGAL ACTIVITY NOTICE: “Medidata Solutions Inc (MDSO) CFO Rouven Bergmann Sells 2,000 Shares” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2018/01/22/medidata-solutions-inc-mdso-cfo-rouven-bergmann-sells-2000-shares-3.html.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply